Supplementary Figure 1 from Sensitivity of Glioblastomas to Clinically Available MEK Inhibitors Is Defined by Neurofibromin 1 Deficiency

Authors :: Russell O. Pieper
Theodore Nicolaides
Joydeep Mukherjee
I-Li Tan
Wendy L. See
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: PDF file - 809K, Immunoblot analysis of NF1-deficient GBM cells treated with AZD6244

Full Text Access

Tools